CClinicalTrials.gg
CompletedNCT02173938Updated May 4, 2015

Novel Psychosocial Influences on Smoking Cessation

An observational study in Smoking, sponsored by Rutgers, The State University of New Jersey. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-05-04.

Sponsored by Rutgers, The State University of New Jersey · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
61
Ages
18 Years and older
Sex
Female
01

Study summary

Our overall research goal is to determine how these novel psychosocial factors impact cessation. This pilot study will answer how dual use of other tobacco products, direct to consumer marketing, and the new phenomenon of butting-out and relighting influences cessation, and how understanding impulsivity and task persistence could lead to new and improved behavioral interventions for tobacco dependence. Answers to these pilot questions will lead to the publication of several manuscripts and provide important feasibility data to design large, well-powered clinical trials, population-level epidemiological studies, and contribute to furthering the field of tobacco treatment.

02

Conditions studied

  • Smoking

Keywords

  • Smokers
  • outpatient
  • Tobacco Dependence Treatment Program
03

In context

Lead sponsor

Rutgers, The State University of New Jersey is the lead sponsor of 496 studies on the registry; 130 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 30 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adult smokers 18 years and older seeking treatment for quitting smoking

Inclusion criteria

  • smokers 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • non-English speaking participants
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
61 participants (actual)
Patient registry
No

Groups and cohorts

  • Treatment seekers

    Other: Tobacco Dependence Treatment

Interventions

  • OtherTobacco Dependence Treatment

    face to face, outpatient tobacco dependence treatment based on the Public Health Service guidelines for treating tobacco use and dependence

06

What researchers measure

Primary outcomes

  1. Number of patients who have quit smoking

    Time frame: 6 months post quit date

07

Study locations

1 site
  • Tobacco Dependence Program, Rutgers University
    New Brunswick, New Jersey 08901, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02173938
Lead sponsor
Rutgers, The State University of New Jersey
Responsible party
Michael B. Steinberg, MD, MPH, FACP (Associate Professor of Medicine, Rutgers, The State University of New Jersey) — Principal investigator
First posted
Jun 25, 2014
Start date
Aug 2012
Primary completion
Apr 2015
Completion
Apr 2015
Last update
May 4, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion